Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A mutant dihydrofolate reductase-thymidylate synthase from Leishmania major as a selectable marker in transfection experiments.

Molecular and biochemical parasitology - 1 Jul 1996

Arrebola R, Olmo A, Camacho A, Ruiz-Pérez L M, González-Pacanowska D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dose-Response Relationship, Drug
Share to Drug Resistance
Share to Leishmania major
Share to Methotrexate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multienzyme Complexes

Share to Selection, Genetic

Share to Tetrahydrofolate Dehydrogenase

Share to Thymidylate Synthase

Source

Identifiers

PMID: 8844682
DOI: 10.1016/0166-6851(96)02649-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A mutant dihydrofolate reductase-thymidylate synthase from Leishmania major as a selectable marker in transfection experiments.PMID 8844682Read ↗

Double targeted gene replacement for creating null mutants.Semantic proximity Read ↗

DNA Integration in Leishmania Genome: An Application for Vaccine Development and Drug Screening.Semantic proximity Read ↗

Selection against the Dihydrofolate Reductase-Thymidylate Synthase ( DHFR-TS ) Locus as a Probe of Genetic Alterations in Leishmania majorSemantic proximity Read ↗

Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes.Semantic proximity Read ↗

Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductaseSemantic proximity Read ↗

Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.Semantic proximity Read ↗

The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genomeSemantic proximity Read ↗

Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.Semantic proximity Read ↗

Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.Semantic proximity Read ↗

Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future ProspectsSemantic proximity Read ↗

Bifunctional thymidylate synthase‐dihydrofolate reductase in protozoaSemantic proximity Read ↗

pRIBOTEX expression vector: a pTEX derivative for a rapid selection of Trypanosoma cruzi transfectantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.